Royalty Pharma eases condition for Elan offer
Royalty Pharma eases condition for Elan offer Yahoo/AP
View ArticleRoyalty Pharma offer for Elan gets little support
Royalty Pharma offer for Elan gets little support Yahoo/AP
View ArticleElan says Amarin deal 'still an opportunity we are considering'
Elan says Amarin deal 'still an opportunity we are considering' The Fly on the Wall
View ArticleElan CEO Says Alternatives Exist If Shareholders Reject Deals
Elan CEO Says Alternatives Exist If Shareholders Reject Deals Bloomberg
View ArticleU.S. court freezes Royalty's bid for drugmaker Elan
U.S. court freezes Royalty's bid for drugmaker Elan Reuters
View ArticleRoyalty Pharma Extends $6.4B Takeover Over for Elan
Royalty Pharma Extends $6.4B Takeover Over for Elan Bloomberg
View ArticleRoyalty Pharma Raises Elan Offer to $6.7 Billion Plus CVR
Royalty Pharma Raises Elan Offer to $6.7 Billion Plus CVR Bloomberg
View ArticleRoyalty Pharma ups bid for Irish drug firm to $8bn
Royalty Pharma ups bid for Irish drug firm to $8bn Trade Arabia
View ArticleElan Board Rejects $6.7 Billion Royalty Pharma Offer
Elan Board Rejects $6.7 Billion Royalty Pharma Offer Bloomberg
View ArticleElan shareholders sort through improving deals as vote looms
Elan shareholders sort through improving deals as vote looms Fierce Pharma
View ArticleElan Risking $2 Billion If Royalty Pharma Walks: Real M&A
Elan Risking $2 Billion If Royalty Pharma Walks: Real M&A Bloomberg
View ArticleDivisive Elan boss Martin faces ownership showdown
Divisive Elan boss Martin faces ownership showdown Reuters
View ArticleElan Drops as Royal Pharma Says Takeover May Fail
Elan Drops as Royal Pharma Says Takeover May Fail Bloomberg
View ArticleJ&J Says It Sells Final Stake in Elan for $332 Million
J&J Says It Sells Final Stake in Elan for $332 Million Bloomberg
View ArticleElan Inviting Royalty Pharma Bid Shows Hostility Easing
Elan Inviting Royalty Pharma Bid Shows Hostility Easing Bloomberg
View ArticleJ&J Says It Sells Final Stake in Elan for $332 Million
J&J Says It Sells Final Stake in Elan for $332 Million Bloomberg
View ArticleElan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now
Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now TheStreet.com
View ArticleRoyalty Pharma lets takeover bid for drugmaker Elan expire, decides against...
Royalty Pharma lets takeover bid for drugmaker Elan expire, decides against court challenge Yahoo/AP
View ArticleForest Laboratories one of several suitors for Elan, report says
Forest Laboratories one of several suitors for Elan, report says Marketwatch
View Article
